Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 1
2019 1
2020 2
2021 1
2022 3
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean han tae su[au] (42 results)?
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.
Lin GW, Xu C, Chen K, Huang HQ, Chen J, Song B, Chan JKC, Li W, Liu W, Shih LY, Chuang WY, Kim WS, Tan W, Peng RJ, Laurensia Y, Cheah DMZ, Huang D, Cheng CL, Su YJ, Tan SY, Ng SB, Tang TPL, Han K, Wang VY, Jia WH, Pei Z, Li YJ, Gao S, Shi Y, Hu Z, Zhang F, Zhang B, Zeng YX, Shen H, He L, Ong CK, Lim ST, Chanock S, Kwong YL, Lin D, Rothman N, Khor CC, Lan Q, Bei JX; International NKTCL Working Group. Lin GW, et al. Among authors: tan sy. Lancet Oncol. 2020 Feb;21(2):306-316. doi: 10.1016/S1470-2045(19)30799-5. Epub 2019 Dec 23. Lancet Oncol. 2020. PMID: 31879220
We recruited a discovery cohort of 700 cases with NKTCL and 7752 controls without NKTCL of Han Chinese ancestry from 19 centres in southern, central, and northern regions of China, and four independent replication samples including 717 cases and 12 650 controls. ...
We recruited a discovery cohort of 700 cases with NKTCL and 7752 controls without NKTCL of Han Chinese ancestry from 19 centres in so …
Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma.
Tian BW, Han CL, Dong ZR, Tan SY, Wang DX, Li T. Tian BW, et al. Among authors: tan sy. Cancers (Basel). 2022 Aug 21;14(16):4036. doi: 10.3390/cancers14164036. Cancers (Basel). 2022. PMID: 36011030 Free PMC article. Review.
Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients.
Han CL, Tian BW, Yan LJ, Ding ZN, Liu H, Mao XC, Tian JC, Xue JS, Tan SY, Dong ZR, Yan YC, Hong JG, Chen ZQ, Wang DX, Li T. Han CL, et al. Among authors: tan sy. Cancer Immunol Immunother. 2023 Jul;72(7):1957-1969. doi: 10.1007/s00262-023-03390-x. Epub 2023 Feb 22. Cancer Immunol Immunother. 2023. PMID: 36811662 Free PMC article. Review.
A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response.
Ma YL, Yang YF, Wang HC, Yang CC, Yan LJ, Ding ZN, Tian BW, Liu H, Xue JS, Han CL, Tan SY, Hong JG, Yan YC, Mao XC, Wang DX, Li T. Ma YL, et al. Among authors: tan sy. Front Pharmacol. 2023 Feb 24;14:1101749. doi: 10.3389/fphar.2023.1101749. eCollection 2023. Front Pharmacol. 2023. PMID: 36909185 Free PMC article.
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Han CL, Tian BW, Yan LJ, Ding ZN, Liu H, Pan GQ, Zhang X, Mao XC, Tan SY, Li RZ, Wang DX, Dong ZR, Yan YC, Li T. Han CL, et al. Among authors: tan sy. Expert Rev Anticancer Ther. 2024 May;24(5):303-312. doi: 10.1080/14737140.2024.2341723. Epub 2024 Apr 16. Expert Rev Anticancer Ther. 2024. PMID: 38623811 Review.
20 results